Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06420973
Status:
RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-05-11
Brief Title:
RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression
Sponsor:
Peking University Cancer Hospital Institute
Organization:
Peking University Cancer Hospital Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-16
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-05-17
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09-17
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-11
First Submit QC Date:
May 16 2024
Study First Post Date:
2024-05-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-16
Last Update Post Date:
2024-05-20
Last Update Post Date Type:
ACTUAL